204 related articles for article (PubMed ID: 36376369)
1. Long non-coding RNAs as novel prognostic biomarkers for breast cancer in Egyptian women.
El-Helkan B; Emam M; Mohanad M; Fathy S; Zekri AR; Ahmed OS
Sci Rep; 2022 Nov; 12(1):19498. PubMed ID: 36376369
[TBL] [Abstract][Full Text] [Related]
2. Circulating LncRNAs landscape as potential biomarkers in breast cancer.
Pourramezan Z; Attar FA; Yusefpour M; Azizi M; Oloomi M
Cancer Rep (Hoboken); 2023 Feb; 6(2):e1722. PubMed ID: 36274054
[TBL] [Abstract][Full Text] [Related]
3. Prognostic value of long noncoding RNAs in gastric cancer: a meta-analysis.
Gao S; Zhao ZY; Wu R; Zhang Y; Zhang ZY
Onco Targets Ther; 2018; 11():4877-4891. PubMed ID: 30147339
[TBL] [Abstract][Full Text] [Related]
4. Serum Long Non-Coding RNAs PVT1, HOTAIR, and NEAT1 as Potential Biomarkers in Egyptian Women with Breast Cancer.
El-Fattah AAA; Sadik NAH; Shaker OG; Mohamed Kamal A; Shahin NN
Biomolecules; 2021 Feb; 11(2):. PubMed ID: 33670447
[TBL] [Abstract][Full Text] [Related]
5. Systematic analysis of lncRNA-miRNA-mRNA competing endogenous RNA network identifies four-lncRNA signature as a prognostic biomarker for breast cancer.
Fan CN; Ma L; Liu N
J Transl Med; 2018 Sep; 16(1):264. PubMed ID: 30261893
[TBL] [Abstract][Full Text] [Related]
6. Unleash multifunctional role of long noncoding RNAs biomarker panel in breast cancer: a predictor classification model.
Toraih EA; El-Wazir A; Ageeli EA; Hussein MH; Eltoukhy MM; Killackey MT; Kandil E; Fawzy MS
Epigenomics; 2020 Jul; 12(14):1215-1237. PubMed ID: 32812439
[No Abstract] [Full Text] [Related]
7. CCAT1 and CCAT2 long noncoding RNAs, located within the 8q.24.21 'gene desert', serve as important prognostic biomarkers in colorectal cancer.
Ozawa T; Matsuyama T; Toiyama Y; Takahashi N; Ishikawa T; Uetake H; Yamada Y; Kusunoki M; Calin G; Goel A
Ann Oncol; 2017 Aug; 28(8):1882-1888. PubMed ID: 28838211
[TBL] [Abstract][Full Text] [Related]
8. Long Noncoding RNAs as Prognostic Markers for Colorectal Cancer in Saudi Patients.
Siddique H; Al-Ghafari A; Choudhry H; AlTurki S; Alshaibi H; Al Doghaither H; Alsufiani H
Genet Test Mol Biomarkers; 2019 Aug; 23(8):509-514. PubMed ID: 31328973
[No Abstract] [Full Text] [Related]
9. Expression profiling revealed up-regulation of three lncRNAs in breast cancer samples.
Mohebi M; Sattari A; Ghafouri-Fard S; Modarressi MH; Kholghi-Oskooei V; Taheri M
Exp Mol Pathol; 2020 Dec; 117():104544. PubMed ID: 32976818
[TBL] [Abstract][Full Text] [Related]
10. lncRNAs in Non-Malignant Tissue Have Prognostic Value in Colorectal Cancer.
Thiele JA; Hosek P; Kralovcova E; Ostasov P; Liska V; Bruha J; Vycital O; Rosendorf J; Opattova A; Horak J; Kralickova M; Vodicka P; Pitule P
Int J Mol Sci; 2018 Sep; 19(9):. PubMed ID: 30205577
[TBL] [Abstract][Full Text] [Related]
11. Upregulation of the long noncoding RNAs DSCAM-AS1 and MANCR is a potential diagnostic marker for breast carcinoma.
Tahmouresi F; Razmara E; Pakravan K; Mossahebi-Mohammadi M; Rouhollah F; Montazeri M; Sarrafzadeh A; Fahimi H; Babashah S
Biotechnol Appl Biochem; 2021 Dec; 68(6):1250-1256. PubMed ID: 33012018
[TBL] [Abstract][Full Text] [Related]
12. Long noncoding RNA SPRY4-IT1 predicts poor patient prognosis and promotes tumorigenesis in gastric cancer.
Peng W; Wu G; Fan H; Wu J; Feng J
Tumour Biol; 2015 Sep; 36(9):6751-8. PubMed ID: 25835973
[TBL] [Abstract][Full Text] [Related]
13. LncRNAs AK058003 and MVIH Overexpression in the Blood Samples of Iranian Breast Cancer Patients.
Akhavan Attar F; Oloomi M; Irani S; Azizi M; Geranpayeh L
Iran Biomed J; 2021 Mar; 25(2):93-8. PubMed ID: 33462225
[TBL] [Abstract][Full Text] [Related]
14. High expression of long non-coding RNA SPRY4-IT1 predicts poor prognosis of clear cell renal cell carcinoma.
Zhang HM; Yang FQ; Yan Y; Che JP; Zheng JH
Int J Clin Exp Pathol; 2014; 7(9):5801-9. PubMed ID: 25337221
[TBL] [Abstract][Full Text] [Related]
15. Upregulation of the long non-coding RNA SPRY4-IT1 indicates a poor prognosis and promotes tumorigenesis in ovarian cancer.
Li H; Liu C; Lu Z; Chen L; Wang J; Li Y; Ma H
Biomed Pharmacother; 2017 Apr; 88():529-534. PubMed ID: 28129625
[TBL] [Abstract][Full Text] [Related]
16. Long non-coding RNA SPRY4-IT1 promotes development of hepatic cellular carcinoma by interacting with ERRĪ± and predicts poor prognosis.
Yu G; Lin J; Liu C; Hou K; Liang M; Shi B
Sci Rep; 2017 Dec; 7(1):17176. PubMed ID: 29214989
[TBL] [Abstract][Full Text] [Related]
17. Increased expression of SPRY4-IT1 predicts poor prognosis and promotes tumor growth and metastasis in bladder cancer.
Zhao XL; Zhao ZH; Xu WC; Hou JQ; Du XY
Int J Clin Exp Pathol; 2015; 8(2):1954-60. PubMed ID: 25973088
[TBL] [Abstract][Full Text] [Related]
18. Clinical significance of SPRY4-IT1 in efficacy and survival prediction in breast cancer patients undergoing neoadjuvant chemotherapy.
Zheng A; Zhang L; Song X; Jin F
Histol Histopathol; 2020 Apr; 35(4):361-370. PubMed ID: 31638266
[TBL] [Abstract][Full Text] [Related]
19. Comparative evaluation of long non-coding RNA-based biomarkers in the urinary sediment and urinary exosomes for non-invasive diagnosis of bladder cancer.
Qiu T; Xue M; Li X; Li F; Liu S; Yao C; Chen W
Mol Omics; 2022 Dec; 18(10):938-947. PubMed ID: 36164958
[TBL] [Abstract][Full Text] [Related]
20. Investigating the diagnostic performance of HOTTIP, PVT1, and UCA1 long noncoding RNAs as a predictive panel for the screening of colorectal cancer patients with lymph node metastasis.
Gharib E; Anaraki F; Baghdar K; Ghavidel P; Sadeghi H; Nasrabadi PN; Peyravian N; Aghdaei HA; Zali MR; Mojarad EN
J Cell Biochem; 2019 Sep; 120(9):14780-14790. PubMed ID: 30993787
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
